Back to Results
First PageMeta Content
Aptamer / Medical research / Peptides / CD30 / Anaplastic large-cell lymphoma / Brentuximab vedotin / Preclinical imaging / Molecular imaging / Medicine / Lymphoma / Medical imaging


Theranostics 2014, Vol. 4, Issue 9 Ivyspring International Publisher Research Paper
Add to Reading List

Document Date: 2014-07-20 05:18:58


Open Document

File Size: 1,59 MB

Share Result on Facebook

City

Santa Clara / Houston / Coralville / Clara / SPECT / /

Company

Jackson Laboratory / McDermott / PerkinElmer / Cancer Pathology Laboratory / /

Country

United States / /

/

Event

FDA Phase / /

Facility

Bar Harbor / Baylor College of Medicine / Houston Methodist Research Institute / Houston Methodist Hospital / Weill Cornell Medical College of Cornell University / /

IndustryTerm

tumor-type specific imaging / clinical applications / tumor type-specific imaging / body imaging / resultant imaging signal / magnetic resonance imaging / cancer therapies / vivo imaging / in vivo imaging probes / selective tumor imaging / complicated imaging procedures / molecular imaging / chemical modification / In vivo fluorescence imaging / imaging / in vivo specific tumor imaging / residual aptamer probe products / fluorescence molecular imaging / in vivo imaging / body bioluminescent imaging / ssDNA imaging probes / long-lasting tumor imaging / aptamer-based molecular imaging / chemical antibodies / tumor imaging / long-lasting imaging signal / /

MedicalCondition

CD30-positive lymphoma tumors / CD30-expressing lymphoma tumor / T cell lymphoma / lymphoblastic lymphoma / lymphoma / KMH2 lymphoma cells / control tumors / CD30+ lymphomas / carcinoma / resected tumors / CD30-expressing lymphoma cells / CD30-expressing lymphoma / xenograft tumors / formalin-fixed and paraffin-embedded tumor / control breast cancer / CD30-expressing lymphoma tumors / breast cancer / pancreatic cancer / CD30-negative leukemia / head and neck tumor / leukemia / tumor / several cultured tumor / different xenograft tumors / Cancer / control tumor / tumors / disease / histiocytic lymphoma / CD30-negative control tumor / both xenograft tumors / tumour / Relapsed CD30-Positive Lymphomas / lymphomas / pancreatic carcinoma / Hodgkin lymphoma / lymphoma cells / breast tumors / control breast cancer tumors / breast cancer tumors / CD30-expressing tumor / control CD30-negative lymphoma tumors / lung cancer / anaplastic large cell lymphoma / personalized cancer / SCID / lymphoma tumors / carcinomas / lymphoma tumor / hyper-metabolically active tumors / LNCaP prostate carcinoma / /

MedicalTreatment

radiation therapy / Immunotherapy / radiation / Gene therapy / cancer therapies / antibody therapy / /

NaturalFeature

ICG channel / /

Organization

National Institute of Health / Department of Pathology / Cornell University / Houston Methodist Hospital / Houston Methodist Research Institute / Baylor College of Medicine / Houston / Systemic administration / FDA / Weill Cornell Medical College / /

Person

Youli Zu / Gene Ther / Clifford Chao / Ray J / Rebecca Kirk / Barbara Savoldo / Sandip Basu / David L Schwartz / Steven J Frank / Mark Raffeld / /

/

Position

reporter for cell staining / Director of Hematopathology / Director / reporter for cell pellet imaging / Cy3 reporter / Corresponding author / imaging reporter / Professor and Medical Director / near-infrared IRD800CW reporter / Major / IRD800CW reporter / reporter / /

Product

penicillin / CD30 / /

ProvinceOrState

Texas / Connecticut / Iowa / /

PublishedMedium

PLoS One / /

RadioStation

Sheehan AM / Blamire AM / /

Technology

radiation / technology of MRI / tomography / antibodies / MRI / drug discovery / Biomaterials / magnetic resonance imaging / /

URL

http /

SocialTag